| Primary |
| Diarrhoea |
37.7% |
| Drug Use For Unknown Indication |
18.3% |
| Multiple Myeloma |
5.1% |
| Product Used For Unknown Indication |
4.6% |
| Large Intestine Carcinoma |
3.4% |
| Antifungal Prophylaxis |
2.9% |
| Cardiac Failure |
2.9% |
| Hypertension |
2.9% |
| Infection |
2.9% |
| Plasma Cell Myeloma |
2.9% |
| Head And Neck Cancer |
2.3% |
| Pain |
2.3% |
| Cardiac Failure Chronic |
1.7% |
| Diabetes Mellitus |
1.7% |
| Haematochezia |
1.7% |
| Neoplasm Malignant |
1.7% |
| Vomiting |
1.7% |
| Chemotherapy |
1.1% |
| Colon Cancer |
1.1% |
| Enterocolitis |
1.1% |
|
| Respiratory Failure |
11.4% |
| Urinary Retention |
9.1% |
| Hepatic Function Abnormal |
6.8% |
| Overdose |
6.8% |
| Portal Venous Gas |
6.8% |
| Drug Ineffective |
4.5% |
| Faeces Discoloured |
4.5% |
| Intraocular Pressure Increased |
4.5% |
| Liver Function Test Abnormal |
4.5% |
| Nausea |
4.5% |
| Pneumatosis Intestinalis |
4.5% |
| Protein-losing Gastroenteropathy |
4.5% |
| Renal Impairment |
4.5% |
| Shock |
4.5% |
| Thrombocytopenia |
4.5% |
| Vomiting |
4.5% |
| Angina Pectoris |
2.3% |
| Azoospermia |
2.3% |
| Cataract |
2.3% |
| Dehydration |
2.3% |
|
| Secondary |
| Diarrhoea |
20.0% |
| Antifungal Prophylaxis |
13.2% |
| Product Used For Unknown Indication |
10.5% |
| Drug Use For Unknown Indication |
8.6% |
| Crohn's Disease |
7.7% |
| Multiple Myeloma |
7.3% |
| Hypertension |
4.5% |
| Fungal Infection |
4.1% |
| Diabetes Mellitus |
3.6% |
| Breast Cancer |
2.7% |
| Cardiac Failure |
2.3% |
| Plasma Cell Myeloma |
2.3% |
| Head And Neck Cancer |
1.8% |
| Large Intestine Carcinoma |
1.8% |
| Nasopharyngitis |
1.8% |
| Panic Disorder |
1.8% |
| Prophylaxis |
1.8% |
| Colon Cancer |
1.4% |
| Pyrexia |
1.4% |
| Vomiting |
1.4% |
|
| Ureteric Rupture |
24.3% |
| Musculoskeletal Stiffness |
8.1% |
| Drug Ineffective |
5.4% |
| Idiopathic Thrombocytopenic Purpura |
5.4% |
| Portal Venous Gas |
5.4% |
| Respiratory Failure |
5.4% |
| Stevens-johnson Syndrome |
5.4% |
| Visual Acuity Reduced |
5.4% |
| Vomiting |
5.4% |
| Arthralgia |
2.7% |
| Blood Lactate Dehydrogenase Increased |
2.7% |
| Colour Blindness |
2.7% |
| Dehydration |
2.7% |
| Hallucination |
2.7% |
| Ileus Paralytic |
2.7% |
| Pneumatosis Intestinalis |
2.7% |
| Prescribed Overdose |
2.7% |
| Renal Failure |
2.7% |
| Sudden Death |
2.7% |
| Urinary Incontinence |
2.7% |
|
| Concomitant |
| Prophylaxis |
14.3% |
| Hiv Infection |
13.0% |
| Diarrhoea |
12.5% |
| Drug Use For Unknown Indication |
7.1% |
| Hypertension |
6.8% |
| Product Used For Unknown Indication |
5.2% |
| Insomnia |
4.5% |
| Colorectal Cancer |
3.8% |
| Breast Cancer |
3.7% |
| Constipation |
3.6% |
| Acquired Immunodeficiency Syndrome |
3.4% |
| Chronic Hepatitis C |
3.1% |
| Nausea |
3.0% |
| Diabetes Mellitus |
2.9% |
| Rectal Cancer |
2.4% |
| Crohn's Disease |
2.3% |
| Colon Cancer |
2.3% |
| Relapsing-remitting Multiple Sclerosis |
2.1% |
| Rash |
2.1% |
| Stomatitis |
1.9% |
|
| White Blood Cell Count Decreased |
15.3% |
| Vomiting |
9.4% |
| Platelet Count Decreased |
6.4% |
| Pyrexia |
6.0% |
| Renal Failure Acute |
6.0% |
| Interstitial Lung Disease |
5.5% |
| Pneumonia |
4.7% |
| Diarrhoea |
4.3% |
| Pseudomembranous Colitis |
4.3% |
| Renal Failure |
4.3% |
| Renal Impairment |
4.3% |
| Hepatic Function Abnormal |
3.8% |
| Liver Disorder |
3.8% |
| Nausea |
3.8% |
| Sudden Death |
3.4% |
| Urinary Tract Infection |
3.4% |
| Hypoglycaemia |
3.0% |
| Peritonitis |
3.0% |
| Stomatitis |
3.0% |
| Febrile Neutropenia |
2.6% |
|
